Inscripta® develops innovative, sustainable, and affordable biomanufacturing solutions for a variety of applications and industries, including agriculture, chemicals, animal and human health solutions, personal care, and pharmaceuticals.
Inscripta® uses GenoScaler™, a proprietary next-generation microbial strain engineering platform based on over 200 patents and relying on ultra-high-throughput CRISPR+ technologies and cutting-edge artificial intelligence and machine learning tools, to manufacture and supply ingredients at scale under rapid timelines.
Founded in 2015, Inscripta® is headquartered in Pleasanton, CA.
